Parkhurst Laser MedSpa Consultation - October 2019

SurgiVision Consultants, Inc / Kristine A. Romine, MD

- SurgiVision ® Consultants, Inc. Guy M. Kezirian, MD, MBA, FACS is a board-certified ophthalmologist who is the founder of SurgiVision® Consultants, Inc., an ophthalmic consulting firm founded in 1995. SurgiVision® Consultants, Inc. is located in Scottsdale, Arizona and has administered several successful panel track FDA approvals for medical devices, including first approvals for the Summit and Visx excimer laser systems for LASIK and multiple approvals for the WaveLight laser excimer laser system prior to WaveLight’s acquisition by Alcon, and has consulted on several regulatory projects in ophthalmology and audiology.

SurgiVision® Consultants, Inc. has provided strategy and/or regulatory consulting services for Alcon, Bausch and Lomb, Visx, Abbot, eyeonics,

AcuFocus, Wavetec, and several other companies in the ophthalmic space. In addition to consulting services, SurgiVision® Consultants, Inc. provides the DataLink series of products to support regulatory studies, monitor clinical outcomes, generate nomograms and support surgical planning.

SurgiVision® Consultants, Inc. developed the PHYSICIAN CEO® program collaboration with the Kellogg School of Management at Northwestern University, SurgiVision® Consultants, Inc. in 2015, providing accelerated business and leadership training to physicians.

Dr. Kezirian holds a BSc from McGill University in Montreal, Canada. He obtained his medical doctorate (MD) at Brown University, interned at the Tufts-Harvard Faulkner Hospital near Boston, Massachusetts, completed an ophthalmology residency at Lenox Hill Hospital in New York City, and a fellowship in oculoplastics at the New York College of Medicine in Albany, NY. Dr. Kezirian is an active member in several professional societies (AAO, ASCRS, ESCRS, AECOS, ISRS) and is the founder and Chairman of the Refractive Surgery Alliance, a professional organization with over 350 members across the globe.

Dr. Kezirian has participated on FDA guidance development committees and on ANSI advisory committees. In addition, Dr. Kezirian has authored more than thirty articles in the peer-review literature.

Page 28 CONFIDENTIAL